ALL
Clinical trials for ALL explained in plain language.
Never miss a new study
Get alerted when new ALL trials appear
Sign up with your email to follow new studies for ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested for tough leukemia in young adults
Disease control Recruiting nowThis early-stage study aims to find out if adding the drug ruxolitinib to standard chemotherapy is safe and tolerable for adolescents and young adults (ages 18-40) newly diagnosed with a specific, hard-to-treat type of acute lymphoblastic leukemia (ALL). The main goal is to check…
Matched conditions: ALL
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Lifesaving cord blood transplants tested for kids without matched donors
Disease control Recruiting nowThis study is testing the safety of using cord blood for transplants in children and young adults (up to age 21) with life-threatening blood cancers or genetic blood disorders who do not have a perfectly matched donor. The main goal is to measure how many patients survive the fir…
Matched conditions: ALL
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Experimental cell therapy targets Tough-to-Treat leukemia in adults
Disease control Recruiting nowThis study is testing an experimental cell therapy called CD19 CAR-T for adults newly diagnosed with a specific, aggressive type of leukemia (Philadelphia chromosome-positive ALL). The therapy involves collecting and genetically modifying a patient's own immune cells to better fi…
Matched conditions: ALL
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for leukemia patients when cancer returns after transplant
Disease control Recruiting nowThis study tests whether the drug Inotuzumab can eliminate tiny amounts of returning cancer cells in patients with acute lymphoblastic leukemia (ALL) who have already undergone a stem cell transplant. The goal is to prevent a full cancer relapse and improve survival. Researchers …
Matched conditions: ALL
Phase: PHASE2 • Sponsor: Sheng-Li Xue, MD • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
15-Year watch begins for patients who received experimental cancer cell therapy
Disease control Recruiting nowThis study will monitor 1,000 people for 15 years after they received an experimental T-cell therapy for blood cancers like leukemia. The goal is to track long-term safety and see how well the treatment continues to work over time. No new treatment is given in this study; researc…
Matched conditions: ALL
Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Testing a liquid lifeline for kids who Can't swallow pills
Knowledge-focused Recruiting nowThis study aims to understand how children's bodies process a liquid form of the cancer drug venetoclax, which is made by crushing tablets. It involves 30 children and young adults with blood cancers who cannot swallow pills and are already receiving this liquid medicine as part …
Matched conditions: ALL
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
Building a bridge for health research in isolated communities
Knowledge-focused Recruiting nowThis project is creating a contact list of Amish and Mennonite community members who are willing to be contacted about future medical research studies. The goal is to make it easier for researchers to find appropriate participants to study genetic health conditions that are more …
Matched conditions: ALL
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC